CAS: 24938-16-7; 2-(Dimethylamino)Ethyl Methacrylate Compound With Butyl Methacrylate And Methyl Methacrylate (1:1:1)

该化合物是一种合成聚合物,具有各种特性,在各种应用中都有用.这种聚合物是由三种单体聚合物组成的:丁基甲基丙烯酸酯,有助于灵活性和疏水性能;二甲基氨基甲基乙基甲基丙烯酸酯,引入氨基组,能够增强粘合度和提供pH灵敏度;甲基甲基甲基丙烯酸酯,为聚合物结构增添了硬性和强度.由此产生的共聚物通常具有良好的热稳定性,化学抗力和机械强度,适合涂层,粘合剂和密封剂.此外,氨基聚氨基体的存在可以与其他材料进行潜在互动,增强其配方的多用途性.其特性可以通过调整成份单体的比,使成型单体能在油漆,墨盒和生物医学装置等行业中具体应用.

英文名称2-(Dimethylamino)Ethyl Methacrylate Compound With Butyl Methacrylate And Methyl Methacrylate (1:1:1)
中文名称聚丙烯酸树脂Ⅳ
IUPAC名称2-(Dimethylamino)ethyl methacrylate compound with butyl methacrylate and methyl methacrylate (1:1:1)
其它别名2-Propenoic Acid, 2-Methyl-, Butyl Ester, Polymer With 2-(Dimethylamino)Ethyl 2-Methyl-2-Propenoate And Methyl 2-Methyl-2-Propenoate; Eudragit-E; N,N-Dimethylaminoethylmethacrylat, Butylmethacrylat, Methylmethacrylat-Copolymer; Amino Methacrylate Copolymer (1.5 G); Polyacrylic Resin ⅳ; 2-Methyl-2-Propenoic Acid Butyl Ester Polymer With 2-(Dimethylamino)Ethyl 2-Methyl-2-Propenoate And Methyl 2-Methyl-2-Propenoate; Basic Butylated Methacrylate Copolyme; Allyl Diglycol Carbonate Eudragit ⅳ
CAS编号24938-16-7
MFCD编号:MFCD01742439
EINECS号:627-095-7
分子式:C21H37NO6
分子量:399.53
产品CID: 1202852
产品分类催化剂及助剂 → 聚合物

相似结构搜索
InChIKey: NEDGUIRITORSKL-UHFFFAOYSA-N
InChI=1S/C8H15NO2.C8H14O2.C5H8O2/c1-7(2)8(10)11-6-5-9(3)4;1-4-5-6-10-8(9)7(2)3;1-4(2)5(6)7-3/h1,5-6H2,2-4H3;2,4-6H2,1,3H3;1H2,2-3H3…
计算化学: 氢键受体数7.0氢键供体数0.0可旋转键数12.0

物理性质

沸点187 °C at 760mmHg
闪点>250 °C
密度3>g/ cm3
PSA:82.14
LogP:3.3086
折射率[n]D/20 1,380-1,385
外观形态无色至黄色粉末
储存条件2-8°C
产品应用该化合物用于制造含有固态药品配方以抑制不愉快的有机性能的异索比德和热熔物质.

MSDS等安全信息

GHS象形图
GHS符号GHS09;
注释: Environment
危险类别水生慢性毒性类别2
特定目标器官毒性 - 单次接触类别3
皮肤致敏类别1
危险描述H411 |对水生生物有毒并具有长期持续影响.
H335 |可能引起呼吸道刺激.
H317 |可能引起皮肤过敏反应.
UN编号NONH for all modes of transport

欧盟法规

C&L通报

合成工艺路线路线简述

海关参考信息

2901210000-乙烯
2901220000-丙烯
2905121000-正丙醇
2905130000-正丁醇
💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
详情请参考：📖 海关编码查询和海关进出口税则

专利信息

专利号:WO-2004074215-A1
优先权日:2003-02-03
标题 :Process for preparation of clopidogrel, its salts and pharmaceutical compositions
发明人：NADKARNI SUNIL SADANAND; PATEL HASMUKH MATHURBHAI
权利人:NADKARNI SUNIL SADANAND; PATEL HASMUKH MATHURBHAI
摘要:The invention discloses an improved process for racemization of methyl (R)Â(-) alpha-(2-chlorophenyl)-6,7-dihydro-thieno[3,2-c]pyridine-5(4H)-acetate , a stereoisomer formed in the synthesis of clopidogrel i.e. methyl (S)-(+)-alphaÂ (2-chlorophenyl)-6,7-dihydro-thieno[3,2-c]pyridine-5(4H)-acetate or its salts. The invention is also for an improved process for production of clopidogrel or its pharmaceutically acceptable salts. The invention further discloses novel clopidogrel salts and pharmaceutical compositions comprising them.

专利号:EP-2078025-A2
优先权日:2006-09-22
标题:Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof

专利号:SI-22383-A
优先权日:2006-09-22
标题:A new process for the synthesis of clopidogrel and a novel form of its pharmaceutically acceptable salts

专利号:MX-2009002267-A
优先权日:2006-08-28
标题:PROCEDURE AND INTERMEDIARIES FOR THE SYNTHESIS OF DERIVATIVES AND INTERMEDIARIES OF (3-ALQUIL-5-PIPERIDIN-1-IL-3,3A-DIHIDRO-PIRAZOLO [1,5-A] PIRIMIDIN-7-IL) -AMINO.

专利号:WO-2008034912-A2
优先权日:2006-09-22
标题:Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof

专利号:US-6991807-B2
优先权日:2000-02-24
标题 :Antibiotic composition
发明人：RUDNIC EDWARD M; ISBISTER JAMES D; TREACY JR DONALD J; WASSINK SANDRA E
权利人:ADVANCIS PHARMACEUTICAL CORP
摘要:Disclosed are antibiotic products for delivering at least two different antibiotics, wherein the products are comprised of at least three or four dosage forms with different release profiles and the at least two different antibiotics comprise at least one protein synthesis inhibiting antibiotic and at least one non-protein synthesis inhibiting antibiotic.